(Total Views: 94)
Posted On: 01/16/2019 8:55:21 AM
Post# of 98294
![Avatar](https://investorshangout.com/images/ProfileImages/312670036_21945_no_avatar_available.png)
$QBIO Q BioMed Adds Clinical Psychologist at Yale's Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001
NEW YORK, January 16, 2019 /PRNewswire/ --
Strategy and Clinical Trial Design Specialist Provides Expertise for the Clinical Trial Design and Regulatory Requirements of QBM-001
QBM-001 Developed to Treat a Pediatric Non-Verbal Disorder which impacts 18,000 children each year in the U.S and a similar amount in Europe.
https://finance.yahoo.com/news/q-biomed-adds-...00973.html
NEW YORK, January 16, 2019 /PRNewswire/ --
Strategy and Clinical Trial Design Specialist Provides Expertise for the Clinical Trial Design and Regulatory Requirements of QBM-001
QBM-001 Developed to Treat a Pediatric Non-Verbal Disorder which impacts 18,000 children each year in the U.S and a similar amount in Europe.
https://finance.yahoo.com/news/q-biomed-adds-...00973.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Scroll down for more posts ▼